Michael Hyatt is Director at ENDO PHARMACEUTICALS HOLDINGS INC (ENDP). They have made 5 open-market trades across 1 company since 2006, most recently 2021-06-11.
CIK 0001034273
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 5 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ENDP | SELL | 2016-03-01 | 2016-03-03 | $42.19 | $288K | -24.7% | -34.3% | -61.6% |
| ENDP | SELL | 2015-11-11 | 2015-11-12 | $55.48 | $444K | -11.9% | +0.1% | -14.7% |
| ENDP | SELL | 2011-11-08 | 2011-11-08 | $32.31 | $162K | -11.9% | +0.1% | +0.1% |
| ENDP | SELL | 2010-12-03 | 2010-12-07 | $36.43 | $364K | -11.9% | +0.1% | +0.1% |
| ENDP | SELL | 2006-01-24 | 2006-01-26 | $27.52 | $5.5M | -11.9% | +0.1% | +0.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.